Deferasirox Therapy in Children With Fanconi Aplastic Anemia

Journal of Pediatric Hematology/Oncology, 05/14/2012

Deferasirox is an oral, easily applicable, and effective iron chelator; baseline hepatotoxicity and nephrotoxicity may increase the development of toxic side effects in children with Fanconi aplastic anemia (FAA). Patients with FAA receiving deferasirox treatment should be followed up closely for these side effects.

Print Article Summary Cat 2 CME Report